Enfusion Other Operating Expenses from 2010 to 2025

ENFN Stock  USD 11.10  0.04  0.36%   
Enfusion Other Operating Expenses yearly trend continues to be very stable with very little volatility. Other Operating Expenses is likely to drop to about 188.2 M. Other Operating Expenses is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. View All Fundamentals
 
Other Operating Expenses  
First Reported
2010-12-31
Previous Quarter
195.5 M
Current Value
188.2 M
Quarterly Volatility
96 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Enfusion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enfusion's main balance sheet or income statement drivers, such as Tax Provision of 3.6 M, Net Interest Income of 1.8 M or Depreciation And Amortization of 12.1 M, as well as many indicators such as Price To Sales Ratio of 4.47, Dividend Yield of 0.0034 or PTB Ratio of 13.6. Enfusion financial statements analysis is a perfect complement when working with Enfusion Valuation or Volatility modules.
  
Check out the analysis of Enfusion Correlation against competitors.
To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.

Latest Enfusion's Other Operating Expenses Growth Pattern

Below is the plot of the Other Operating Expenses of Enfusion over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Enfusion. It is also known as Enfusion overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Enfusion's Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Enfusion's overall financial position and show how it may be relating to other accounts over time.
Other Operating Expenses10 Years Trend
Slightly volatile
   Other Operating Expenses   
       Timeline  

Enfusion Other Operating Expenses Regression Statistics

Arithmetic Mean101,326,186
Geometric Mean74,871,593
Coefficient Of Variation94.71
Mean Deviation73,689,631
Median45,158,000
Standard Deviation95,968,096
Sample Variance9209.9T
Range342.4M
R-Value0.66
Mean Square Error5628.3T
R-Squared0.43
Significance0.01
Slope13,212,331
Total Sum of Squares138148.1T

Enfusion Other Operating Expenses History

2025188.2 M
2024195.5 M
2023162.6 M
2022162.3 M
2021387.6 M
202073.5 M

About Enfusion Financial Statements

Enfusion investors utilize fundamental indicators, such as Other Operating Expenses, to predict how Enfusion Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Other Operating Expenses195.5 M188.2 M
When determining whether Enfusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enfusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enfusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enfusion Stock:
Check out the analysis of Enfusion Correlation against competitors.
To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.82)
Earnings Share
0.03
Revenue Per Share
2.19
Quarterly Revenue Growth
0.139
Return On Assets
0.0305
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.